|
2025
|
Invention
|
Histone deacetylase inhibitors for use in immunotherapy.
Provided are methods and compositions f... |
|
2024
|
Invention
|
Methods and compositions for treating viral or virally-induced conditions.
Provided are methods ... |
|
2023
|
Invention
|
Dosing methods for hdac inhibitor compounds. Described herein is a method of treating a cancer in... |
|
|
Invention
|
Hdac inhibitor solid state forms.
The present disclosure relates to various solid-state forms of... |
|
|
Invention
|
Hdac inhibitor solid state forms. The present disclosure relates to the crystalline mesylate Form... |
|
|
Invention
|
Methods of treating autoimmune disorders with histone deacetylase inhibitors. Described herein ar... |
|
2022
|
Invention
|
Hdac inhibitor solid state forms. The present disclosure relates to various solid-state forms of ... |
|
|
Invention
|
Cancer treatment combinations.
Described herein is a method of treating a cancer or tumor in an ... |
|
|
Invention
|
Cancer treatment combinations. Described herein is a method of treating a cancer or tumor in an i... |
|
2021
|
Invention
|
Methods and compositions for treating viral or virally-induced conditions. Provided are methods a... |
|
|
Invention
|
Hdac inhibitor solid state forms.
The present disclosure relates to the crystalline mesylate For... |
|
2020
|
Invention
|
Dosages for hdac treatment with reduced side effects.
Described herein are certain dosing schedu... |
|
|
Invention
|
Methods of treating virally associated cancers with histone deacetylase inhibitors.
Described he... |
|
2019
|
Invention
|
Epigenetic modifiers for use in cellular immunotherapy.
Described herein are methods and composi... |
|
2006
|
Invention
|
Histone deacetylase inhibitors. Compounds of formula: (I), and salts, N-oxides, hydrates and solv... |
